A double-blind placebo-controlled trial of intra-articular triamcinolone with and without physiotherapy in adhesive capsulitis
Completed
- Conditions
- Adhesive capsulitis of the shoulderMusculoskeletal DiseasesAdhesive capsulitis of shoulder
- Registration Number
- ISRCTN25152388
- Lead Sponsor
- Arthritis Research Campaign (ARC) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Painful shoulder for more than 4 weeks and less than 6 months with greater than 25% limitation of active and passive range of movement in external rotation and abduction as compared with the contralateral shoulder.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of triamcinolone in treating adhesive capsulitis of the shoulder?
How does intra-articular triamcinolone with physiotherapy compare to standard-of-care treatments for adhesive capsulitis?
Which inflammatory biomarkers correlate with response to triamcinolone in adhesive capsulitis patients?
What are the long-term adverse events of intra-articular triamcinolone in adhesive capsulitis trials?
Are there alternative corticosteroids or combination therapies for adhesive capsulitis compared to triamcinolone in the ISRCTN25152388 trial?